Targeting tumors with non-viral gene delivery systems

Drug Discovery Today

Volumn 7, Issue 8, 2002, Pages 479-485

  Ogris, Manfred ^a   Wagner, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REPORTER GENE; REVIEW; TUMOR; TUMOR GROWTH; ANIMAL; GENETICS; METHODOLOGY; NEOPLASM; PATHOLOGY;

ANIMAL; DRUG CARRIERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMAN; NEOPLASMS; ANIMALS; HUMANS;

DRUG CARRIER;

EID: 0037088992     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02243-2     Document Type: Review

References (47)

1. Gene therapy: a brief overview over the past, present and future
2. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function
3. Targeting tumor angiogenesis with gene therapy
4. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors
5. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery
6. Gene delivery with synthetic (non viral) carriers
7. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
8. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery
9. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo
10. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes
11. Gene therapy on trial
12. Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications
13. Cationic polymer based gene delivery systems
14. Bioapplications of PAMAM dendrimers
15. Polyethylenimines: a family of potent polymers for nucleic acid delivery
16. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
17. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application
18. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis
19. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
20. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery
21. Gene delivery using a receptor-mediated gene transfer system targeted to hepatocellular carcinoma cells
22. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells
23. Application of membrane-active peptides for drug and gene delivery across cellular membranes
24. Properties of cytotoxic peptide-formed ion channels
25. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems
26. Melittin enables efficient vesicular escape and enhanced nuclear access of non-viral gene delivery vectors
27. Polyethylenimine-mediated gene delivery: a mechanistic study
28. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus
29. Harnessing nuclear localization pathways for transgene delivery
30. Stabilized plasmid-lipid particles for systemic gene therapy
31. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts
32. Novel lipidic vectors for gene transfers
33. Prodrug activation enzymes in cancer gene therapy
34. Cytochrome P450-based cancer gene therapy: recent advances and future prospects
35. Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitors
36. Successful use of a plant gene in the treatment of cancer in vivo
37. Technology evaluation: gene therapy (IL-2), Valentis Inc
38. The role of CpG motifs in immunostimulation and gene therapy
39. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant
40. Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector
41. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001
42. Targeting gene expression to hypoxic tumor cells
43. Heat-induced gene expression as a novel targeted cancer gene therapy strategy
44. Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection